Showing 1 - 10 of 99
News, Gwynne Dyer, Published on 17/01/2026
» Any day now, the United States will "come to the rescue" of the protesters in the streets of Iran's cities and American bombers will unleash "hell" on the minions of the theocratic regime -- or not, as the case may be.
Oped, Gwynne Dyer, Published on 05/01/2026
» The demonstrations began again in Iran last week, only two years after the "Woman, Life, Freedom" movement convulsed the country for months. However, the current protests are potentially much broader than that episode because they are driven by the collapse in Iran's currency, the rial (now 1,420,000 to the US dollar), and the explosive rise in the cost of living.
News, Gwynne Dyer, Published on 22/11/2025
» Twenty years of strict sanctions on Iran by both the United States and the United Nations did not bring down the regime of the ayatollahs. Half a dozen major waves of non-violent protest involving several thousand deaths have not brought it down either. Even last June's massive bombing campaign by Israel and the US did not bring it to heel.
Roger Crutchley, Published on 07/09/2025
» Last month PostScript mentioned the strange phenomenon of how the 1950s British ventriloquist Peter Brough and his schoolboy dummy Archie Andrews had a successful radio show called Educating Archie. Although Brough's ventriloquist skills was a visual art and seemed wasted on radio it didn't appear to bother listeners.
Oped, M Niaz Asadullah, Published on 20/08/2025
» The past year has been marked by a series of revolutions and political shocks as young people across Asia and Africa have taken to the streets, demanding accountable governments, fairer societies, and economic opportunities -- a wave of resistance that Binaifer Nowrojee has aptly termed "youthquakes".
Oped, Muhammad Makmun Rasyid, Published on 07/07/2025
» In May, Indonesia's counter-terrorism unit arrested an 18-year-old man in Gowa, South Sulawesi, on charges of spreading Islamic State (IS) propaganda and inciting bomb attacks on social media. Identified only as MAS, the suspect represents a deeply troubling development in Southeast Asia's struggle against terrorism: the rise of youth radicalisation driven entirely by online exposure.
Oped, Gwynne Dyer, Published on 01/07/2025
» Leading an entire country for a few years is a steep learning curve, but it's useful experience. Being in power for a dozen years makes most leaders arrogant and careless, but some remain more or less functional. Being in power for more than 30 years just makes you stupid. Consider Cambodia's Hun Sen and Iran's Supreme Leader Ayatollah Ali Khamenei.
Oped, Brahma Chellaney, Published on 26/06/2025
» Israel and the United States have dealt punishing blows to Iran's nuclear infrastructure. "Operation Rising Lion" and "Operation Midnight Hammer" have been portrayed as precision strikes that will stop the Islamic Republic's nuclear programme in its tracks. But whatever the bombings might have achieved tactically, they risk forfeiting strategically, as Iran is now more convinced than ever that nuclear weapons are the only way to deter future aggression and ensure the regime's survival.
News, John J. Metzler, Published on 21/06/2025
» Well, it seems to have started. Israeli airstrikes on Iran's nuclear research and development sites have ushered in a new phase of the Middle East conflicts, which began when Tehran's Hamas terrorist proxies invaded Israel on Oct 7, 2023, murdering 1,200 people and taking 254 hostages.
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.